Adrian Bradley

Partner

Dr Adrian Bradley is a Partner at Cleveland Scott York. His practice is devoted to helping clients achieve their strategic goals by devising and implementing intellectual property strategies to support them.

His practice focusses on healthcare, with specialisms in medical devices and pharmaceuticals. Having trained as a patent attorney in the pharmaceutical industry with Wyeth (now Pfizer), Adrian has a detailed knowledge of product lifecycle management in the sector. He has worked extensively on Supplementary Protection Certificates and advises on regulatory data exclusivity.

He has a particular interest in technology transfer, regularly advising academic institutions around the world on obtaining effective protection for their innovations through patents. His enthusiasm for technology transfer stems from a belief that pioneering medical innovations made in university research laboratories deserve to be in the hands of doctors and saving the lives of patients. He undertakes a significant amount of pro bono work in areas of unmet clinical need in developing countries, such as tuberculosis in India.

Dr Bradley has acted as lead IP counsel for many university spin-out companies, in areas as diverse as neurodegeneration, anti-infectives, peptide synthesis, and image-guided medical procedures. He also acts as European counsel for a number of university research foundations in the United States, notably the University of Utah Research Foundation.

In addition to his technology transfer practice, Dr Bradley acts as European representative for a multinational medical device company. He has handled numerous matters of commercial significance, including oppositions and appeals at the European Patent Office, particularly in the field of minimally invasive surgical methods.

He is a member of the Business Advisory Board of the Institute of Organic Chemistry and Biochemistry (IOCB) in the Czech Republic, a visiting lecturer at the University of Reading, and has delivered many seminars and lectures on technology transfer (and other IP related subjects) in the UK, Europe, Asia and the United States. He is a member of the continuing professional development committee of the Chartered Institute of Patent Attorneys.

  • Government Use of Patented Inventions (28 April 2020)
  • Freedom to Operate in the Life Sciences (25 March 2020)
  • Patents in the Pharmaceutical Sector – Key Developments (7 February 2020 – Czech Patent Office)
  • Plausibility in the UK and EPO – Recent Developments (23 January 2020 – Chartered Institute of Patent Attorneys Merseyside Meeting)
  • IP for Medtech – Essential Knowledge (16 May 2019 – Med-Tech Innovation Expo 2020)
  • Chemical Claims Drafting (30 April 2019 – Chartered Institute of Patent Attorneys)

  • Partner 2009
  • Patents
  • Pharmaceuticals, Agrochemicals Chemistry
  • Appeals oppositions before the EPO
  • Supplementary Protection Certificates
  • Data Exclusivity
  • IAM 1000 & Strategy 300
  • MA Chemistry (1st class), Balliol College, Oxford
  • PhD Organic Chemistry, University College, London
  • Chartered Patent Attorney 2004
  • European Patent Attorney 2004

“Named as a Patent Star 2020 in Patent Prosecution and Patent Strategy & Counseling.”

IP Stars

“Medical device and pharmaceutical specialist Adrian Bradley is a key contact.”

Legal 500 (Trade Marks), 2020

“Adrian Bradley focuses on medical devices and pharmaceuticals drafting. His SPC and data exclusivity knowledge is sure to interest those looking for a well-rounded practitioner who covers all angles.”

IAM Patent 1000, 2020
Adrian Bradley's posts

Articles, Videos & Podcasts